AstraZeneca reports boost in cancer drug sales

LONDON — Anglo-Swedish drugmaker AstraZeneca is reporting its first quarterly sales in years on the back of new cancer treatments.

The company said Friday that product sales rose 4 percent in the fourth quarter to $5.49 billion, buoyed by new drugs such as bladder cancer treatment Imfinzi, and lymphoma medication Calquence.

It was the first increase since the third quarter of 2014.

AstraZeneca says it expects product sales to increase "in the low single digits" this year.

Despite encouraging news on the sales front, net income fell 29 percent to $1.3 billion. Core operating profit, which excludes restructuring and acquisition-related costs to give a better picture of underlying performance, fell 12 percent to $1.79 billion.

CEO Pascal Soriot says the sales increase shows AstraZeneca is "steadily turning a corner."

Must Read

London air pollution 'very high'; heavy fog...

Jan 23, 2017

Cold, still weather in London prompted the mayor to issue a "very high" air pollution alert for the...

Longtime British Vogue editor Alexandra Shulman...

Jan 25, 2017

The top editor at British Vogue plans to step down after a quarter century at the helm of the...

UK pardons thousands convicted under past...

Jan 31, 2017

Thousands of men convicted under now-abolished anti-homosexuality laws in Britain have been...

Vibrant Tate show traces David Hockney's artistic...

Feb 6, 2017

It's not often an artist finds himself occupying 12 rooms of London's leading museum of British art...

Prince William calls for end to stigma on mental...

Feb 7, 2017

Prince William is speaking out about ending the stigma surrounding mental health treatment

Sign up now!